Background The COVID-19 pandemic, caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), is of a scale not seen since the 1918 influenza pandemic …

Although COVID-19 presents primarily as a lower respiratory tract infection transmitted via
air droplets, increasing data suggest multiorgan involvement in patients that are infected …

In this cross-sectional study, we evaluated skeletal muscle strength and physical
performance (1-min sit-to-stand and short physical performance battery tests), dyspnea …

Since December 2019, the coronavirus disease 2019 (COVID-19) has become a public
health emergency. COVID-19 has already been classified as a category B infectious disease …

Background: In hospitalized patients recovering from the SARS-coronavirus-2 disease 19
(COVID-19), high prevalence of muscle weakness and physical performance impairment …

OBJECTIVES: Significant variability exists in physical rehabilitation modalities and dosage
used in the ICU. Our objective was to investigate the effect of physical rehabilitation in ICU …

Background Few studies have evaluated muscle strength in COVID-19 ICU survivors. We
aimed to report the incidence of limb and respiratory muscle weakness in COVID-19 ICU …

The global pandemic caused by SARS-CoV-2, or COVID-19, continues to impact all facets of
daily life. Clinical manifestations of COVID-19 commonly include musculoskeletal symptoms …

This paper describes a patient who developed diffuse and symmetrical muscle weakness
after a long stay in the intensive care unit (ICU) due to coronavirus disease 2019 (COVID …

Intensive care unit-acquired weakness (ICU-AW), a common neuromuscular complication
associated with patients in the ICU, is a type of skeletal muscle dysfunction that commonly …